Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0000895345-25-000055
Filing Date
2025-02-14
Accepted
2025-02-14 11:14:05
Documents
2
Period of Report
2024-12-31
Effectiveness Date
2025-02-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2003
2 informationtable.html INFORMATION TABLE  
2 informationtable.xml INFORMATION TABLE 7340
  Complete submission text file 0000895345-25-000055.txt   10816
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 13F-HR | Act: 34 | File No.: 028-25193 | Film No.: 25624988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)